The significance of particle/globule-sizing measurements in the safe use of intravenous lipid emulsions

被引:23
作者
Driscoll, DF [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
intravenous fat emulsion; large diameter tail; emulsion stability;
D O I
10.1081/DIS-120015371
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Intravenous lipid emulsions (IVLEs) are an integral part of the clinical care of acutely ill patients who are unable to sustain nutrient homeostasis by mouth for protracted periods of time. They are oil-in-water emulsions stabilized by an emulsifier that imparts a net negative charge to the surface of the globules which stabilizes the dispersion. The mean droplet size of commercial IVLEs is approximately 300 nm. When the emulsion becomes unstable, these homogenously distributed droplets begin to aggregate and ultimately coalesce into large fat globules. Phase separation typically occurs when the volume-weighted percent fat greater than five micrometers (PFAT > 5 mum) exceeds 0.4% of the total lipid present in a formulation. Moreover when the size of the droplets reaches a dimension of 5 mum or larger the infused globules may lodge into the pulmonary capillaries and produce a fat embolism syndrome. Thus, in the assessment of stability and the subsequent safety of IVLEs, any particle sizing measurement technique must be able to reliably quantify the volume-weighted fraction of the coalesced fat globules that statistically comprise the distribution tail of the largest diameter droplets of the emulsion. Of the four common particle sizing methods reviewed, light obscuration or light extinction, is the only one that measures fat globules accurately enough to determine the clinical. safety of IVLEs.
引用
收藏
页码:679 / 687
页数:9
相关论文
共 19 条
[11]   METABOLIC EFFECTS OF LONG-CHAIN AND MEDIUM-CHAIN TRIGLYCERIDE EMULSIONS IN HUMANS [J].
KLEIN, S ;
MILES, JM .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1994, 18 (05) :396-397
[12]   Particle size in parenteral fat emulsions, what are the true limitations? [J].
Koster, VS ;
Kuks, PFM ;
Lange, R ;
Talsma, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 134 (1-2) :235-238
[13]   EFFECT OF FAST VS SLOW INTRALIPID INFUSION ON GAS-EXCHANGE, PULMONARY HEMODYNAMICS, AND PROSTAGLANDIN METABOLISM [J].
MATHRU, M ;
DRIES, DJ ;
ZECCA, A ;
FAREED, J ;
ROONEY, MW ;
RAO, TLK .
CHEST, 1991, 99 (02) :426-429
[14]   EFFECTS OF LONG-CHAIN TRIGLYCERIDE EMULSIONS ON RETICULOENDOTHELIAL SYSTEM FUNCTION IN HUMANS [J].
SEIDNER, DL ;
MASCIOLI, EA ;
ISTFAN, NW ;
PORTER, KA ;
SELLECK, K ;
BLACKBURN, GL ;
BISTRIAN, BR .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1989, 13 (06) :614-619
[15]   THE STABILITY OF INTRAVENOUS FAT EMULSIONS IN TOTAL PARENTERAL-NUTRITION MIXTURES [J].
WASHINGTON, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 66 (1-3) :1-21
[16]   STABILITY OF TPN MIXTURES COMPOUNDED FROM LIPOFUNDIN-S AND AMINOPLEX AMINO-ACID SOLUTIONS - COMPARISON OF LASER DIFFRACTION AND COULTER-COUNTER DROPLET SIZE ANALYSIS [J].
WASHINGTON, C ;
SIZER, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 83 (1-3) :227-231
[17]  
1998, PHARMACOPEIAL FORUM, V24, P6988
[18]  
2000, US PHARM, V24, P2149
[19]  
2000, US PHARM XXIV, P1971